Guided Therapeutics Debt/Equity
What is the Debt/Equity of Guided Therapeutics?
The Debt/Equity of Guided Therapeutics, Inc. is -2.17
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on OTC compared to Guided Therapeutics
What does Guided Therapeutics do?
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.
Companies with debt/equity similar to Guided Therapeutics
- i-CABLE Communications has Debt/Equity of -2.19
- DGTL has Debt/Equity of -2.19
- Samoth Oilfield has Debt/Equity of -2.18
- Bioasis Technologies has Debt/Equity of -2.18
- SolidusGold has Debt/Equity of -2.17
- TrackX has Debt/Equity of -2.17
- Guided Therapeutics has Debt/Equity of -2.17
- CardioComm Solutions has Debt/Equity of -2.17
- Australian Potash has Debt/Equity of -2.16
- TPG Pace Beneficial Finance has Debt/Equity of -2.15
- Carebook Technolgies Inc has Debt/Equity of -2.15
- Gujarat Poly Electronics has Debt/Equity of -2.15
- Eagle Ride Investment has Debt/Equity of -2.15